Arthur Becker

Arthur Becker serves as Chair at CargoMetrics Technologies Inc. since February 2023 and at Visgenx, Inc. since March 2021, where efforts focus on developing gene therapy for Dry AMD. Additionally, Arthur Becker holds the position of Executive Chair at Vatic AI since May 2022 and serves as Chief Executive Officer and Chairman at OncoPep, Inc. since April 2019, where the company is developing a cancer vaccine based on licensed peptides from the Dana Farber Cancer Institute. As Managing Member at Atlantic Investors, LLC since January 2002, Arthur Becker oversees real estate investments in New York and Miami and has been Managing Director at Madison Technology Group LLC since January 2001. Previous board membership includes NextRNA Therapeutics from June 2021 to January 2023 and serving as Venture Partner at COBRO VENTURES, INC from February 2021 to January 2023. Educational background includes a BA from Bennington College (1969-1972) and studies at The Tuck School of Business at Dartmouth (1973-1974).